http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-970070009-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C09K19-588 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C09K19-3497 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D513-04 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C09K19-58 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C09K19-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D513-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G02F1-13 |
| filingDate | 1997-04-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 1997-11-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-970070009-A |
| titleOfInvention | Imidazothiazole |
| abstract | The compound of formula (1) has a clear tendency to form a liquid crystalline S (smetic) phase.n n n n n n n n Thus, the optically inert compound of formula (1) also has a smectic phase, in particular a Sc phase, further inclined on the nematic phase. On the other hand, the optically active compound of formula (1) has an inclined smectic phase, in particular a chiral Sc phase, further on the cholesteric phase. The compounds mentioned are therefore particularly suitable as ingredients and dopants, respectively, for the preparation of a very wide range of liquid crystalline mixtures. A class of compounds consisting of compounds of formula (1) provides a wide range of novel components and mixtures for optimization and modification of liquid crystalline mixtures. |
| priorityDate | 1996-04-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 32.